<DOC>
	<DOCNO>NCT00879229</DOCNO>
	<brief_summary>Ambrisentan endothelin receptor antagonist use treatment pulmonary hypertension ( PH ) . Based research suggest role endothelin-1 pathogenesis idiopathic pulmonary fibrosis ( IPF ) poor prognosis patient IPF also diagnose PH , study design evaluate effectiveness safety ambrisentan patient population .</brief_summary>
	<brief_title>ARTEMIS-PH - Study Ambrisentan Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Hypertension , Pulmonary</mesh_term>
	<mesh_term>Pulmonary Fibrosis</mesh_term>
	<mesh_term>Idiopathic Pulmonary Fibrosis</mesh_term>
	<mesh_term>Idiopathic Interstitial Pneumonias</mesh_term>
	<mesh_term>Endothelin Receptor Antagonists</mesh_term>
	<criteria>Selected Weight ≥ 40 kg screen Diagnosis IPF base modified American Thoracic SocietyEuropean Respiratory Society guideline Diagnosis PH base follow hemodynamic requirement : mean pulmonary artery pressure ( mPAP ≥ 25 mm Hg ; pulmonary vascular resistance &gt; 240 dyne.sec/cm^5 ; pulmonary capillary wedge pressure leave ventricular enddiastolic pressure ≤ 15 mm Hg Forced vital capacity ( FVC ) ≥ 40 % Able walk least 50 meter two 6minute walk test If receive calcium channel blocker , lowdose oral corticosteroid , immunosuppressive , cytoxic , antifibrotic drug dose must stable . Selected Diagnosis PH primarily due etiology IPF Surgical lung biopsy diagnosis Usual Interstitial Pneumonia Other know cause interstitial lung disease Evidence significant obstructive lung disease Recent hospitalization acute exacerbation IPF Recent active pulmonary upper respiratory tract infection Left ventricular ejection fraction &lt; 40 % Serum creatinine ≥ 2.5 mg/dL Required hemodialysis , peritoneal dialysis , hemofiltration Female subject pregnant breastfeed Recent treatment PH endothelin receptor antagonist ( ERA ) , phosphodiesterase type 5 inhibitor , prostacyclin derivative Recent treatment high dose oral corticosteroid Recent treatment ( within 4 week prior screen ) imatinib mesylate ( Gleevec ) Alanine aminotransferase aspartate aminotransferase lab value great 1.5 x upper limit normal range Discontinued ERA treatment adverse reaction associate liver function test abnormality</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Idiopathic Pulmonary Fibrosis</keyword>
	<keyword>Pulmonary Hypertension</keyword>
	<keyword>PH</keyword>
	<keyword>IPF</keyword>
	<keyword>Ambrisentan</keyword>
	<keyword>ERA</keyword>
	<keyword>Endothelin Receptor Antagonist</keyword>
	<keyword>Cardiovascular</keyword>
</DOC>